| Date | Title | Description |
| 26.06.2025 | Capitainer strengthens board to accelerate global growth | Capitainer strengthens board to accelerate global growth
Thu, Jun 26, 2025 10:50 CET Report this content
Capitainer AB has appointed a new Board of Directors as the company accelerates its international expansion and scales up to meet growi... |
| 02.05.2025 | Deepull's €50 Million Series C: A Game Changer in Sepsis Diagnostics | In the world of medical diagnostics, speed is life. Every second counts, especially when it comes to sepsis—a condition that claims lives at an alarming rate. Enter deepull, a Barcelona-based company that has just secured €50 million in an ... |
| 30.04.2025 | deepull Raises €50M in Series C Financing | deepull, a Barcelona, Spain-based medical diagnostics company, raised €50M in Series C funding.
The round was led by Columbus Venture Partners, Panakès Partners, and Mérieux Equity Partners with participation from existing investors Asabys ... |
| 29.04.2025 | deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection | deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners
Barcel... |
| 21.10.2022 | Spain-based DeepUll raises €13M to advance it early sepsis recognition platform | Barcelona-based DeepUll, a medical diagnostics company, announced on Thursday, October 20, that it has raised €13M in a Series B round of funding led by Innvierte, part of the Spanish Ministry of Science and Innovation (CDTI), and an undisc... |
| 20.10.2022 | DeepUll raises €13M Series B financing to progress early sepsis recognition platform | Financing led by new investors Innvierte and an undisclosed strategic investor with participation from existing investors Kurma Partners, Alta Life sciences, UI Investissement and Axis
BARCELONA, Spain – October 20, 2022 – DeepUll, a medic... |
| 20.10.2022 | DeepUll Raises €13M in Series B Financing | DeepUll, a Barcelona, Spain-based medical diagnostics company, raised €13M in Series B funding.
The round was led by Innvierte, with participation from Kurma Partners, Alta Life Sciences, UI Investissement, and Axis Participaciones Empresar... |
| 20.10.2022 | DeepUll raises €13M Series B financing to progress early sepsis recognition platform | DeepUll, a medical diagnostics company developing culture-free, affordable diagnostic solutions for the early identification of sepsis and other acute infections, announces today that it has raised €13 million in a Series B financing round.... |
| 07.07.2020 | DeepUll closes Series A Financing led by Alta Life Sciences and Kurma Partners, to improve early diagnosis of sepsis |
Barcelona, 7 July 2020.- DeepUll announced today the closing of a 3.5 million Euro round Series A financing led by Alta Life Sciences and Kurma Partners and with participation from Axis Participaciones Empresariales and Sofimac Innovati... |
